RNA as performance-enhancers for dendritic cells

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Expert Opinion on Biological Therapy

• Publication date

  2010-03-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1517/14712591003614749PMID 20128707
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Dendritic cells for cancer immunotherapy].

  2012cited by this paper
• Attenuated Expression of A20 Markedly Increases the Efficacy of Double-Stranded RNA-Activated Dendritic Cells As an Anti-Cancer Vaccine1

  2009cited by this paper
• Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients

  2009cited by this paper
• Timing and tuning of CD27–CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology

  2009cited by this paper
• Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients

  2009influential reference
• Cancer immunotherapy: co‐stimulatory agonists and co‐inhibitory antagonists

  2009cited by this paper
• CD28 and CTLA‐4 coreceptor expression and signal transduction

  2009cited by this paper
• Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy

  2009influential reference
• siRNA and Innate Immunity

  2009cited by this paper
• Immune therapy for cancer.

  2009cited by this paper
• Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.

  2008cited by this paper
• Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes

  2008cited by this paper
• Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA.

  2008influential reference
• Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells.

  2008cited by this paper
• Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion

  2008influential reference
• High-Level Antigen Expression and Sustained Antigen Presentation in Dendritic Cells Nucleofected with Wild-Type Viral mRNA but Not DNA

  2008influential reference
• IL‐1, IL‐18, and IL‐33 families of cytokines

  2008cited by this paper
• Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity

  2008cited by this paper
• Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling.

  2008cited by this paper
• Enhanced protein expression by internal ribosomal entry site-driven mRNA translation as a novel approach for in vitro loading of dendritic cells with antigens.

  2008cited by this paper
• Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA‐mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments

  2007cited by this paper
• Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity.

  2007cited by this paper
• Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response.

  2007cited by this paper
• Pivotal Roles of CD4+ Effector T cells in Mediating Agonistic Anti-GITR mAb-Induced-Immune Activation and Tumor Immunity in CT26 Tumors

  2007cited by this paper
• Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells

  2007cited by this paper
• Immunostimulatory monoclonal antibodies for cancer therapy

  2007cited by this paper
• Taking dendritic cells into medicine

  2007cited by this paper
• The Role of the CTLA4 Blockade in the Treatment of Malignant Melanoma

  2007cited by this paper
• High transfection efficiency, gene expression, and viability of monocyte‐derived human dendritic cells after nonviral gene transfer

  2007cited by this paper
• A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer

  2007cited by this paper
• Interleukin-12: Biological Properties and Clinical Application

  2007cited by this paper
• DC-based cancer vaccines.

  2007cited by this paper
• Tregs and rethinking cancer immunotherapy.

  2007cited by this paper
• Glucocorticoid-Induced TNF Receptor Family Related Gene Activation Overcomes Tolerance/Ignorance to Melanoma Differentiation Antigens and Enhances Antitumor Immunity1

  2006cited by this paper
• Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

  2006cited by this paper
• Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.

  2006cited by this paper
• Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.

  2006cited by this paper
• 5'-Triphosphate RNA Is the Ligand for RIG-I

  2006cited by this paper
• The GITR–GITRL interaction: co-stimulation or contrasuppression of regulatory activity?

  2006cited by this paper
• Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease

  2006cited by this paper
• Regulatory T cells, tumour immunity and immunotherapy

  2006cited by this paper
• CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.

  2006cited by this paper
• mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level.

  2006cited by this paper
• Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7

  2005influential reference
• Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization.

  2005cited by this paper
• GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily

  2005influential reference
• Toll-like receptors.

  2005cited by this paper
• Development of humanized antibodies as cancer therapeutics.

  2005cited by this paper
• Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.

  2005cited by this paper
• Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand.

  2005cited by this paper
• Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

  2005cited by this paper
• RNA transfection of dendritic cells.

  2005cited by this paper
• Vaccination with Dendritic Cells Transfected with BAK and BAX siRNA Enhances Antigen-Specific Immune Responses by Prolonging Dendritic Cell Life

  2005cited by this paper
• Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer.

  2005cited by this paper
• Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells

  2005cited by this paper
• The Therapeutic Implications of Intratumoral Regulatory T Cells

  2005cited by this paper
• Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes

  2005cited by this paper
• In vivo ligation of glucocorticoid-induced TNF receptor enhances the T-cell immunity to herpes simplex virus type 1

  2005cited by this paper
• Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer 1

  2005cited by this paper
• Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.

  2004cited by this paper
• Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8

  2004cited by this paper
• Cancer immunotherapy with mRNA‐transfected dendritic cells

  2004cited by this paper
• Small interference RNA modulation of IL‐10 in human monocyte‐derived dendritic cells enhances the Th1 response

  2004cited by this paper
• Cancer immunotherapy: moving beyond current vaccines

  2004cited by this paper
• Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells

  2004cited by this paper
• Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 41

  2004cited by this paper
• Cotransfection of DC with TLR4 and MART-1 RNA induces MART-1-specific responses.

  2004cited by this paper
• Dendritic cell immunotherapy: mapping the way

  2004cited by this paper
• Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA

  2004cited by this paper
• The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

  2004cited by this paper
• CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.

  2004cited by this paper
• Costimulation via Glucocorticoid-Induced TNF Receptor in Both Conventional and CD25+ Regulatory CD4+ T Cells1

  2004cited by this paper
• Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

  2003cited by this paper
• Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

  2003cited by this paper
• Cancer immunotherapy using RNA‐loaded dendritic cells

  2003cited by this paper
• Immunotherapy with Autologous, Human Dendritic Cells Transfected with Carcinoembryonic Antigen mRNA

  2003cited by this paper
• Gene therapy to target dendritic cells from blood to lymph nodes

  2003cited by this paper
• Toll-like receptors.

  2003cited by this paper
• Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells.

  2003cited by this paper
• Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells

  2003cited by this paper
• Free Poly(A) Stimulates Capped mRNA Translation in Vitro through the eIF4G-Poly(A)-binding Protein Interaction*

  2002cited by this paper
• Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines

  2002cited by this paper
• RNA-transfected dendritic cells

  2002cited by this paper
• Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors.

  2002cited by this paper
• Untranslated regions of mRNAs

  2002cited by this paper
• Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance

  2002cited by this paper
• The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer

  2002cited by this paper
• Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells.

  2001cited by this paper
• Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA1

  2001cited by this paper
• Structural and functional analysis of an mRNP complex that mediates the high stability of human beta-globin mRNA.

  2001cited by this paper
• Synthesis and properties of mRNAs containing the novel "anti-reverse" cap analogs 7-methyl(3'-O-methyl)GpppG and 7-methyl (3'-deoxy)GpppG.

  2001cited by this paper
• Structural and Functional Analysis of an mRNP Complex That Mediates the High Stability of Human β-Globin mRNA

  2001cited by this paper
• Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

  2001cited by this paper
• Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

  2000cited by this paper
• Dendritic cells in cancer immunotherapy.

  2000cited by this paper
• CD27 is required for generation and long-term maintenance of T cell immunity

  2000cited by this paper
• Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells.

  2000cited by this paper
• Induction of carcinoembryonic antigen (cea)‐specific cytotoxic t‐lymphocyte responses In vitro using autologous dendritic cells loaded with cea peptide or cea rna in patients with metastatic malignancies expressing cea

  1999cited by this paper
• Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation

  1999cited by this paper
• A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis.

  1997cited by this paper

• Introduction to RNA Vaccines Post COVID-19.

  2024cites this paper
• The Quest for mRNA Vaccines

  2022cites this paper
• Enhanced CD40 and ICOSL expression on dendritic cells surface improve anti-tumor immune responses; effectiveness of mRNA/chitosan nanoparticles

  2018cites this paper
• Introduction to RNA Vaccines.

  2017cites this paper
• The RNAissance period.

  2016cites this paper
• Tissue-resident dendritic cells and diseases involving dendritic cell malfunction.

  2016cites this paper
• Dendritic Cell Targets for Self-Replicating RNA Vaccines

  2015cites this paper
• Technologies of cellular antitumor immune response induction in vitro

  2015cites this paper
• Development of Delivery Strategies Facilitating Broad Application of Messenger RNA Tumor Vaccine

  2014cites this paper
• Messenger RNA (mRNA) nanoparticle tumour vaccination.

  2014cites this paper
• Programming human dendritic cells with mRNA.

  2013cites this paper
• Synthetic Messenger RNA and Cell Metabolism Modulation

  2013cites this paper
• Cell engineering with synthetic messenger RNA.

  2013cites this paper
• RNA pulsed dendritic cells: an approach for cancer immunotherapy.

  2013cites this paper
• Silencing IDO in dendritic cells: A novel approach to enhance cancer immunotherapy in a murine breast cancer model

  2013cites this paper
• Engineering B cells with mRNA.

  2013cites this paper
• Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System

  2012cites this paper
• Nucleofection of a DNA vaccine into human monocyte-derived dendritic cells.

  2012cites this paper
• Anti-tumor immunity of gene vaccine with nucleofection technology

  2011cites this paper
• RNA in cancer vaccine therapy

  2011cites this paper
• Tumor vaccination using messenger RNA: prospects of a future therapy.

  2011cites this paper
• NFĸB-SIGNALWEG-MANIPULIERTE DENDRITISCHE ZELLEN

  2011cites this paper
• Engineering dendritic cells to enhance cancer immunotherapy.

  2011cites this paper
• Gene Carriers and Transfection Systems Used in the Recombination of Dendritic Cells for Effective Cancer Immunotherapy

  2010cites this paper
• Avaliação da transfecção de células dendríticas com RNA tumoral como estratégia para indução de imunidade específica em pacientes com leucemia linfóide crônica.

  2010cites this paper